Papa Sees ‘Speed Bumps’ in Derm

http://www.bloomberg.com/news/articles/2016-05-23/valeant-new-ceo-papa-sees-growth-and-a-very-good-pipeline


Joe Papa, said that while there’s more work to do in dermatology, the company has a “very good pipeline” of new drugs that hasn’t been fully appreciated.

Valeant needs to work its way through “speed bumps” with Walgreens in dermatology, Papa said.

Valeant doesn’t need to sell any of its businesses, but there are opportunities to divest non-core assets, the CEO said.

“We’re going to bring some additional talent, we just recently hired a new controller to join our company,” Papa said. “There will be some centralization in some of the areas like finance, because it has to happen.”

 

LOL @ Papa saying he doesn't need to sell anything.

 

Papa is delusional.

 

They keep mentioning the "pipeline". But isn't the pipeline drugs just prospects and no knows how each will do?

 

From inside source, Solta and Obagi will be sold before end of June. There are several suitors, most likely buyer is Merz....won't put much of a dent in overall debt but will allow Papa to get company focused back on true Pharma.

 

Lipstick on a pig.

 

Solta represents less than 2% of the valeants revenue. It won't put a dent in anything.

 

Correct, Solta nothing more than a distraction to the core business. I've also heard the same as above that it will be the first to be divested or shut down. Personally, since I work for Solta, can't wait to get my severance and leave this shipwreck, run by a bunch of amateurs all the way up to the top. Sooner the better!

 

I hear you. I work for Solta as well. I've never seen such a s**t show. It's a shame because if it ran smoothly and people knew what they were doing it would be a good business. But since Valeant runs it, it's a disaster.

 

In business press today SEC going to force Valeant to act like a grownup and use GAAP. The blanket is pulled back and it aint pretty. Get the popcorn and pull up a chair. Any guesses on how low the stock will go.

 

Stupid stock was up a little for some reason.

 

It's going to crash again after the OIG gets a copy of an email - a clear violation of the federal regulations on drug promotion.